These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8229690)

  • 1. Application of neural networks to pharmacodynamics.
    Veng-Pedersen P; Modi NB
    J Pharm Sci; 1993 Sep; 82(9):918-26. PubMed ID: 8229690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural networks in pharmacodynamic modeling. Is current modeling practice of complex kinetic systems at a dead end?
    Veng-Pedersen P; Modi NB
    J Pharmacokinet Biopharm; 1992 Aug; 20(4):397-412; discussion 413-8. PubMed ID: 1479561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A system approach to pharmacodynamics. Input-effect control system analysis of central nervous system effect of alfentanil.
    Veng-Pedersen P; Modi NB
    J Pharm Sci; 1993 Mar; 82(3):266-72. PubMed ID: 8450420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a variable direction hysteresis minimization approach in describing the central nervous system pharmacodynamic effects of alfentanil in rabbits.
    Modi NB; Veng-Pedersen P
    J Pharm Sci; 1994 Mar; 83(3):351-6. PubMed ID: 8207680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of artificial neural networks in biomedical technologies: an introduction.
    Alvager T; Smith TJ; Vijai F
    Biomed Instrum Technol; 1994; 28(4):315-22. PubMed ID: 7920848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, pharmacodynamics, and rational opioid selection.
    Shafer SL; Varvel JR
    Anesthesiology; 1991 Jan; 74(1):53-63. PubMed ID: 1824743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers.
    Egan TD; Minto CF; Hermann DJ; Barr J; Muir KT; Shafer SL
    Anesthesiology; 1996 Apr; 84(4):821-33. PubMed ID: 8638836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the pharmacokinetics of alfentanil in rabbits, sheep, and dogs.
    Ilkiw JE; Benthuysen JA; McNeal D
    Am J Vet Res; 1991 Apr; 52(4):581-4. PubMed ID: 2053728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic model for acute tolerance development to the electroencephalographic effects of alfentanil in the rat.
    Mandema JW; Wada DR
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1185-94. PubMed ID: 8531080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic-pharmacodynamic modeling in drug development: application to the investigational opioid trefentanil.
    Lemmens HJ; Dyck JB; Shafer SL; Stanski DR
    Clin Pharmacol Ther; 1994 Sep; 56(3):261-71. PubMed ID: 7924121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial neural networks as a novel approach to integrated pharmacokinetic-pharmacodynamic analysis.
    Gobburu JV; Chen EP
    J Pharm Sci; 1996 May; 85(5):505-10. PubMed ID: 8742942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of computer-controlled alfentanil administration in children undergoing cardiac surgery.
    Fiset P; Mathers L; Engstrom R; Fitzgerald D; Brand SC; Hsu F; Shafer SL
    Anesthesiology; 1995 Nov; 83(5):944-55. PubMed ID: 7486179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using neural networks to determine the contribution of danshensu to its multiple cardiovascular activities in acute myocardial infarction rats.
    Chen YC; Cao WW; Cao Y; Zhang L; Chang BB; Yang WL; Liu XQ
    J Ethnopharmacol; 2011 Oct; 138(1):126-34. PubMed ID: 21924339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic system analysis of the biophase level predictor and the transduction function.
    Veng-Pedersen P; Modi NB
    J Pharm Sci; 1992 Sep; 81(9):925-34. PubMed ID: 1432642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a variable direction hysteresis minimization pharmacodynamic approach: cardiovascular effects of alfentanil.
    Modi NB; Veng-Pedersen P
    Pharm Res; 1994 Jan; 11(1):128-35. PubMed ID: 8140044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats: assessment of rapid functional adaptation.
    Cox EH; Kuipers JA; Danhof M
    Br J Pharmacol; 1998 Aug; 124(7):1534-40. PubMed ID: 9723968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic parameter sets of alfentanil revisited: optimal parameters for use in target controlled infusion and anaesthesia display systems.
    Sigmond N; Baechtold M; Schumacher PM; Hartwich V; Schnider TW; Luginbühl M
    Br J Anaesth; 2013 Aug; 111(2):197-208. PubMed ID: 23512864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NeuCube: a spiking neural network architecture for mapping, learning and understanding of spatio-temporal brain data.
    Kasabov NK
    Neural Netw; 2014 Apr; 52():62-76. PubMed ID: 24508754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural network approach for robust and fast calculation of physical processes in numerical environmental models: compound parameterization with a quality control of larger errors.
    Krasnopolsky VM; Fox-Rabinovitz MS; Tolman HL; Belochitski AA
    Neural Netw; 2008; 21(2-3):535-43. PubMed ID: 18234470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of alfentanil in P-glycoprotein-competent and P-glycoprotein-deficient mice: P-glycoprotein efflux alters alfentanil brain disposition and antinociception.
    Kalvass JC; Olson ER; Pollack GM
    Drug Metab Dispos; 2007 Mar; 35(3):455-9. PubMed ID: 17178769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.